Holen Sie sich die Stockscreener-App
375.45
2.64%
-10.29
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$385.74
Offen:
$384.68
24-Stunden-Volumen:
629.63K
Relative Volume:
0.41
Marktkapitalisierung:
$83.29B
Einnahmen:
$76.39B
Nettoeinkommen (Verlust:
$7.81B
KGV:
12.91
EPS:
29.0772
Netto-Cashflow:
$7.93B
1W Leistung:
-7.63%
1M Leistung:
-3.24%
6M Leistung:
-19.97%
1J Leistung:
+3.58%
1-Tages-Spanne:
$375.03
$386.26
1-Wochen-Bereich:
$353.99
$410.83
52-Wochen-Spanne:
$330.00
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
375.45 | 85.57B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
197.78 | 17.16B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
235.69 | 15.02B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.09 | 12.94B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
112.42 | 11.16B | 6.07B | 793.80M | 464.40M | 5.9914 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Is Investigating HCA Healthcar - The National Law Review
HCA Healthcare stock trades near record territory as revenue and earnings expand - ad-hoc-news.de
HCA Healthcare options signal 6.3% move on July 24 earnings - Investing.com
Stocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovis - The Globe and Mail
Why Is Intuitive Surgical Stock Sinking Friday? - Benzinga
Aware Super Pty Ltd as trustee of Aware Super Buys New Stake in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare (HCA) Expected to Release Earnings on Friday - MarketBeat
Why HCA Healthcare (HCA) Is Down 5.7% After Cutting 2026 Earnings Guidance On Payer Mix Shifts - simplywall.st
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc.HCA - PR Newswire
HCA Healthcare Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
HCA Healthcare (NYSE:HCA): Can Care Demand Stay Strong? - Kalkine Media
HCA Healthcare (HCA) Q4 2024 earnings summary - Quartr
HCA Florida Hospitals in North Central Florida Team with Marion Technical College on New Nursing Program - 352today
HCA Healthcare (HCA) TD Cowen 46th Annual Health Care Conference Summary - Quartr
HCA Healthcare (HCA) Q3 2024 earnings summary - Quartr
HCA Healthcare (HCA) Q1 2025 earnings summary - Quartr
HCA Maintained by Barclays -- Price Target Lowered to $402 - GuruFocus
Barclays Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat
HCA Healthcare, Inc.’s Stock Price Soars to $378.85, Witnessing a Robust 4.19% Uptick - Smartkarma
HCA Healthcare Stock Falls as Uninsured Patients and Declining Surgeries Dent Outlook -- Barrons.com - Moomoo
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
HCA Healthcare (HCA) Stock Still Trades At A Discount Despite A 52% Return - Yahoo Finance
HCA Healthcare Had Seen 2026 Revenue $76.5B-$80B >HCA - Moomoo
HCA Maintained by RBC Capital -- Price Target Lowered to $435 - GuruFocus
RBC Capital cuts HCA Healthcare stock price target on guidance concerns - Investing.com
Jump in Uninsured Patients Stings HCA - HCI Innovation Group
5-Day Sell-Off Sends HCA Healthcare Stock Down 14% - Trefis
Bernstein SocGen reiterates HCA Healthcare stock rating on Q2 beat - Investing.com
RBC Capital Adjusts Price Target on HCA Healthcare to $435 From $534, Maintains Outperform Rating - Moomoo
HCA Healthcare Stock Extends A 5-Day Losing Streak To A 14% Loss - Trefis
Barclays Adjusts Price Target on HCA Healthcare to $402 From $427, Maintains Equalweight Rating - marketscreener.com
HCA Healthcare (HCA) Stock Sees Modest Fair Value Cut As Policy Risks Temper Growth Views - Yahoo Finance
HCA Healthcare's Warning Prices In All The Bad News (Upgrade) (NYSE:HCA) - Seeking Alpha
HCA Healthcare (HCA) Shares Plummet After Lowered Earnings Forec - GuruFocus
Principal Financial Group Inc. Sells 3,755 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
Barclays Downgrades HCA Healthcare (HCA) – Here’s Why - Yahoo Finance
HCA Healthcare Updates Q2 Results and 2026 Outlook - TipRanks
HCA Healthcare, Inc. $HCA Shares Bought by Fifth Third Bancorp - MarketBeat
HCA Healthcare Lowers Earnings Outlook, Impacting MedTech Stocks - GuruFocus
HCA Healthcare: Experienced 2Q Payer Mix Shift, Driven by Increase in Uninsured Volume >HCA - Moomoo
What Happened to HCA Healthcare (NYSE:HCA) After Quarterly Results? - Kalkine Media
Why HCA Healthcare (HCA) Is Down 14.1% After Cutting 2026 Guidance on Uninsured Patient Shift - Yahoo Finance
HCA Healthcare, Inc. Stock 12‑Month Price Target Cut to $486.6, Implies 25% Upside - TradingView
A Look at HCA Healthcare Inc (HCA) After 7.0% Decline -- GF Value $453.39 vs Price $363.60 - GuruFocus
HCA Healthcare, Inc.’s Stock Price Takes a Dive, Down 6.95% to $363.60 - Smartkarma
HCA takes $400M hit from exchange coverage losses - Modern Healthcare
GE HealthCare Technologies Inc. (NASDAQ:GEHC) sheds $1.7 billion as HCA warning tests order-growth case - TechStock²
HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
HCA: Healthcare Provider Reduces 2026 EBITDA Forecast - GuruFocus
HCA Healthcare Previews Second Quarter 2026 Results - Florida Hospital News and Healthcare Report
HCA: Firm Lowers 2026 Guidance on Rising Uninsured Population and Related Pressures - Morningstar
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.46%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):